Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms

Clinical trial condition

Neoplasms

Explore clinical trials studying Neoplasms. Study availability and eligibility vary by location and protocol.

7,968 public trials 1,514 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms trial results

Completed

Durvalumab and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors

NCT03911557

Conditions: Diabetes Mellitus, Insulin-Dependent, 12, Neoplasms, Tumor, Solid
Locations: Markey Cancer Center Lexington, Kentucky, United States

View Trial Details

Completed

Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT02812667

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

View Trial Details

Completed

BDB001-101: Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab

NCT03486301

Conditions: Neoplasms, Tumor, Solid
Locations: Florida Cancer Specialists Sarasota, Florida, United States

Atlantic Health Morristown, New Jersey, United States

Tennessee Oncology Nashville, Tennessee, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Completed

Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

NCT04840394

Conditions: Neoplasms, Tumor, Solid
Locations: Florida Cancer Specialists Sarasota, Florida, United States

START MidWest Grand Rapids, Michigan, United States

START San Antonio, Texas, United States

View Trial Details

Completed

BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab

NCT04196530

Conditions: Neoplasms, Tumor, Solid
Locations: Angeles Clinic Los Angeles, California, United States

Florida Cancer Specialists Sarasota, Florida, United States

Tennessee Oncology Nashville, Tennessee, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Completed

BDB001-201: A Clinical Study of BDB001 in Patients With PD-(L)1 Refractory Solid Tumors

NCT04819373

Conditions: Neoplasms, Tumor, Solid
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours

NCT03468426

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Beverly Hills Cancer Center Beverly Hills, California, United States

Winship Cancer Institute Atlanta, Georgia, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View all 43 locations

View Trial Details

Completed

PC001- A Study to Evaluate the Usability of PointCheck

NCT04448301

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +5 more
Locations: Boston Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Managing Anxiety From Cancer (MAC): Testing an Intervention for Anxiety in Older Adults With Cancer and Their Caregivers

NCT03168971

Conditions: Anxiety, Anxiety Disorders, Behavior, +5 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer

NCT03480646

Conditions: Metastatic Castration Resistant Prostate Cancer (mCRPC), Neoplasms
Locations: Alaska Urological Institute Anchorage, Alaska, United States

Beverly Hills Cancer Center (BHCC) Beverly Hills, California, United States

John Wayne Cancer Inst. Duarte, California, United States

UCLA Los Angeles, California, United States

View all 41 locations

View Trial Details